PH-INDUCED IN SITU GELLING SYSTEM OF LOMEFLOXACIN FOR SUSTAINED OCULAR DELIVERY

Authors

  • Abdul Malik P.H Department of Pharmaceutics, Karpagam University, Pollachi Main Road, Coimbatore, Tamilnadu-641021, India
  • S Satyanandam Department of Pharmaceutics, Karpagam University, Pollachi Main Road, Coimbatore, Tamilnadu-641021, India
  • Sunil Murala Department of Pharmaceutics, Karpagam University, Pollachi Main Road, Coimbatore, Tamilnadu-641021, India

Abstract

In the present work, an attempt has been made to formulate pH-induced in-situ gel as an ophthalmic drug delivery system. In situ gels are made from polymers that exhibit phase transition due to physicochemical change in the environment. They can be conveniently dropped as a solution into the conjuctival sac in the eye. Upon contact with the lacrimal fluid, the polymer changes its conformation to form a gel. This delivery system has the ease of administration similar to an opthalmic solution and has a long retention time because of the gel formation. Different polymers for preparing pH induced in-situ gels have been evaluated. The topical application of ophthalmically active drugs to the eye is the most prescribed route of administration for the treatment of various ocular diseases. It is generally agreed that the intraocular bioavailability of topically applied drugs is extremely poor. Upon instillation of an ophthalmic solution; most of the instilled volume is eliminated from the pre-corneal area. This loss is mainly due to drainage of the excess fluid by the nasolacrimal duct or elimination of the solution by tear turnover, which will results in poor ocular bioavailability. Lomefloxacin is member of the fluoroquinolone class of antimicrobial drugs. It is active against a wide range of gram positive and gram negative organisms.

Keywords:

Lomefloxacin, Bioavailability, Antimicrobial drugs, Ophthalmic Drug Delivery System, In situ gels

DOI

https://doi.org/10.25004/IJPSDR.2015.070504

References

1. Bourlais CL, Acar L Zia H, Sado PA, Needhan S. Leverge R. Ophthalmic Drug Delivery Systems – Recent Advances. Progress in Retinal and Eye Research 1998; 17(1): 33-58.
2. Chein YW, Novel Drug Delivery Systems, 2nd edition, volume 29, 269-300, New York, Marcel Dekker Inc., 1993.
3. Martindale, The Complete Drug Reference, 34th edition, 127, 227, Pharmaceutical press.
4. Lieberman HA, Rieger MM and Banker GS, Pharmaceutical Dosage Forms: Disperse System, 2nd edition, volume 2, New York, Marcel dekker Inc. 357-397.
5. Geeta MP, Madhubhai MP. Recent Advances and Challenges in Ocular Drug Delivery Systems. Pharma Times 2007; 39(1):21-25.
6. Peppas NA, Bures P, Leabandung W, Ichikawa H. Hydrogels in Pharmaceutical Formulations. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50:27-46.
7. Panwar R, Sagar BPS. Hydrogels. The Indian Pharmacist 2006; 9-14.
8. El-Kamel AH. In-vitro and in-vivo Evaluation of Pluronic F127-based Ocular Delivery System for Timolol Maleate. International Journal of Pharmaceutics 2000; 241:47-55.
9. Kulkarni MC, Damle AV. Development of Ophthalmic In Situ Gelling Formulation of Flurbiprofen Sodium using Gellan Gum. Indian Drugs 2007; 44(5):373-377.
10. Mitan RG, Dharmesh MM, Jolly RP. In Situ Gel System for Ocular Drug Delivery: A Review. Drug Delivery Technology 2007; 7(3):30-37.
11. Thilekkumar M, Bharathi D, Balasubhramaniam J, Kant S, Pandit JK. pH-induced In Situ Gelling Systems of Indomethacin for Sustained Ocular Delivery. Indian Journal of Pharmaceutical Sciences 2005; 67(3):327-333.
12. Roizer A, Manzuel C, Grove J, Planzonnet B. Gelrite: A Novel, Ion-activated, In Situ Gelling Polymer for Ophthalmic Vehicles Effect on Bioavailability of Timolol. International Journal of Pharmaceutics 1989; 57(2):162-168.
13. Lindell K, Engstrom S. In vitro Release of Timolol from An In Situ Gelling Polymer System. International Journal of Pharmaceutics 1993; 95(1-3):219-228.
14. Kumar S, Haglund BO, Himmelstein KJ. In Situ Forming Gels for Ophthalmic Drug Delivery. Journal of Ocular Pharmacology 1994; 10(1):47-56.
15. Kumar S, Himmelstein KJ. Modification of In Situ Gelling Behavior of Carbopol Solutions by HPMC. Journal of Pharmaceutical Sciences 1995; 84(3):344-348.
16. Cohen S, Lobel E, Trevgoda A, Peled Y. A Novel in Situ Forming Ophthalmic Drug Delivery System from Alginates Undergoing Gellation in the Eye. Journal of Controlled Release 1997; 44(2-3):201-208.

Published

01-09-2015
Statistics
Abstract Display: 377
PDF Downloads: 431
Dimension Badge

How to Cite

“PH-INDUCED IN SITU GELLING SYSTEM OF LOMEFLOXACIN FOR SUSTAINED OCULAR DELIVERY”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 5, Sept. 2015, pp. 401-6, https://doi.org/10.25004/IJPSDR.2015.070504.

Issue

Section

Research Article

How to Cite

“PH-INDUCED IN SITU GELLING SYSTEM OF LOMEFLOXACIN FOR SUSTAINED OCULAR DELIVERY”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 7, no. 5, Sept. 2015, pp. 401-6, https://doi.org/10.25004/IJPSDR.2015.070504.